5-lipoxygenase pathway promotes cell proliferation in human glioma cell lines

Clinical Neuropathology

Volumn 28, Issue 6, 2009, Pages 445-452

  Ishii, K ^a,b   Zaitsu, M ^a   Yonemitsu, N ^c   Kan, Y ^a,b   Hamasaki, Y ^a   Matsuo, M ^a  

^a SAGA UNIVERSITY   (Japan)

^b Saga Handicapped Children's Hospital   (Japan)

^c Sasebo General Hospital   (Japan)

Author keywords

5 lipoxygenase; Brain tumor; Glioma cell lines; Leukotriene

Indexed keywords

ARACHIDONATE 5 LIPOXYGENASE; BESTATIN; DOCEBENONE;

ARTICLE; ASTROCYTOMA; CANCER CELL CULTURE; CANCER INHIBITION; CELL PROLIFERATION; CLINICAL ARTICLE; CONTROLLED STUDY; CRANIOPHARYNGIOMA; ENZYME INHIBITION; EPENDYMOMA; GLIOMA; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LYMPHOMA; MEDULLOBLASTOMA; MENINGIOMA; METASTASIS POTENTIAL; NEPHROBLASTOMA; NEURINOMA; NEUROEPITHELIOMA; OLIGODENDROGLIOMA; PRIORITY JOURNAL; PROTEIN EXPRESSION; TUMOR GROWTH;

EID: 70549103224     PISSN: 07225091     EISSN: None     Source Type: Journal    
DOI: 10.5414/npp28445     Document Type: Article

References (29)

1. Furstenberger G, Krieg P, Muller-Decker K, Habenicht AJ. What are cyclooxygenases and lipoxygenases doing in the driver's seat of carcinogenesis? Int J Cancer. 2006; 119: 2247-2254.
2. Howe LR, Dnnerberg AJ. A role of cyclooxygenase-2 inhibitors in the prevention and treatment of cancer. Semin Oncol. 2002; 29: 111-119.
3. Matsuo M., Yonemitsu N, Zaitsu M, Fukuyama K, Tabuchi K, Hamasaki Y. Expression of prostaglandin H synthase-2 in human brain tumors. Acta Neuropathol (Berl). 2001; 102: 181-187.
4. Joki T, Heese O, Nikas DC, Bello L, Zhang J, Kraeft SK, Seyfried NT, Abe T, Chen LB, Carroll RS, Black PM. Expression of cyclooxygenase 2 (COX-2) in human glioma and in vitro inhibition by a specific COX-2 inhibitor, NS398. Cancer Res. 2000; 60: 4926-4931.
5. Shono T, Tofilon PJ, Bruner JM, Owolabi O, Lang FF. Cyclooxygenase-2 expression in human gliomas: Prognostic significance and molecular correlations. Cancer Res. 2001; 61: 4375-4381.
6. Hennig R, Ding XZ, Tong WG, Schneider MB, Standop J, Friess H, Büchler MW, Pour PM, Adrian TE. 5-Lipoxygenase and leukotriene B4 receptor are expressed in human pancreatic cancers but not in pancreatic ducts in normal tissue. Am J Pathol. 2002; 161: 421-428.
7. Hoque A, Lippman SM, Wu TT, Xu Y, Liang ZD, Swisher S, Zhang H, Cao L, Ajani JA, Xu XC. Increased 5-lipoxygenase expression and induction of apoptosis by its inhibitors in esophageal cancer: a potential target for prevention. Carcinogenesis. 2005; 26: 785-791.
8. Gupta S, Srivastava M, Ahmad N, Sakamoto K, Bostwick DG, Mukhtar H. 5-Lipoxygenase is over-expressed in prostate adenocarcinoma. Cancer. 2001; 91: 737-743.
9. Morris AA, Rodger IW. Leukotrienes and brain. Lancet. 1998; 352: 1487-1488.
10. Black KL, Hoff JT, McGillicuddy JE, Gebarski SS. Increased leukotriene C4 and vasogenic edema surrounding brain tumors in humans. Ann Neurol. 1986; 19: 592-595.
11. Rao AM, Hatcher JF, Kindy MS, Dempsey RJ. Arachidonic acid and leukotriene C4: role in transient cerebral ischemia of gerbils. Neurochem Res. 1999; 24: 1225-1232.
12. Watanabe T, Asano T, Shimizu T, Seyama Y, Takakura K. Participation of lipoxygenase products from arachidonic acid in the pathogenesis of cerebral vasospasm. J Neurochem. 1998; 50: 1145-1150.
13. Simmet T, Luck W, Winking M, Delank WK, Peskar BA. Identification and characterization of cysteinyl-leukotriene formation in tissue slices from human intracranial tumors: evidence for their biosynthesis under in vivo conditions. J Neurochem. 1990; 54: 2091-2099.
14. Inamura T, Abe M, Ikezaki K, Fukui M. Leukotriene C4 contents, synthase and catabolic activity in human meningiomas. Neurol Res. 1992; 14: 405-410.
15. Gaetani P, Rodriguez y Baena R, Marzatico F, Lombardi D, Knerich R, Paoletti P. "Ex vivo" release of eicosanoid from human brain tissue: its relevance in the development of brain edema. Neurosurgery. 1991; 28: 853-858.
16. 2+ mediates lipoxygenase-induced proliferation of U-373 MG human astrocytoma cells. Arch Pharm Res. 1998; 21: 664-670.
17. Winking M, Sarikaya S, Rahmanian A, Jödicke A, Böker DK. Boswellic acids inhibit glioma growth: a new treatment option? J Neurooncol. 2000; 46: 97-103.
18. Boado RJ, Pardridge WM, Vinters HV, Black KL. Differential expression of arachidonate 5-lipoxygenase transcripts in human brain tumors: evidence for the expression of a multitranscript family. Proc Natl Acad Sci USA. 1992; 89: 9044-9048.
19. Zhang L, Zhang WP, Hu H, Wang ML, Sheng WW, Yao HT, Ding W, Chen Z, Wei EQ. Expression patterns of 5-lipoxygenase in human brain with traumatic injury and astrocytoma. Neuropathology. 2006; 26: 99-106.
20. Nathoo N, Prayson RA, Bondar J, Vargo L, Arrigain S, Mascha EJ, Suh JH, Barnett GH, Golubic M. Increased expression of 5-lipoxygenase in high-grade astrocytomas. Neurosurgery. 2006; 58: 347-354.
21. Golubic M, Prayson RA, Vargo L, Bondar J, Barnett GH. Increased expression of 5-lipoxygenase in glioblastomamultiforme. Adv ExpMed Biol. 2003; 525: 205-208.
22. Brock TG. Regulating leukotriene synthesis: the role of nuclear 5-lipoxygenase. J Cell Biochem. 2005; 96: 1203-1211.
23. Shureiqi I, Lippman S. Lipoxygenase modulation to reverse carcinogenesis. Cancer Res. 2001; 61: 6307-6312.
24. Hostanska K, Daum G, Saller R. Cytostatic and apoptosis-inducing activity of boswellic acids toward malignant cell lines in vitro. Anticancer Res. 2002; 22: 2853-2862.
25. Bortuzzo C, Hanif R, Kashfi K, Staiano-Coico L, Shiff SJ, Rigas B. The effect of leukotrienes B and selected HETEs on the proliferation of colon cancer cells. Biochim Biophys Acta. 1996; 1300: 240-246.
26. Tong WG, Ding XZ, Hennig R, Witt RC, Standop J, Pour PM, Adrian TE. Leukotriene B4 receptor antagonist LY293111 inhibits proliferation and induces apoptosis in human pancreatic cancer cells. Clin Cancer Res. 2002; 8: 3232-3242.
27. Ding XZ, Iversen P, Cluck MW, Knezetic JA, Adrian TE. Lipoxygenase inhibitors abolish proliferation of human pancreatic cancer cells. Biochem Biophys Res Commun. 1999; 261: 218-223.
28. Ghosh J. Rapid induction of apoptosis in prostate cancer cells by selenium: reversal by metabolites of arachidonate 5-lipoxygenase. Biochem Biophys Res Commun. 2004; 315: 624-635.
29. Matsuo M, Yoshida N, Zaitsu M, Ishii K, Hamasaki Y. Inhibition of human glioma cell growth by a PHS-2 inhibitor, NS398, and a prostaglandin E receptor subtype EP1-selective antagonist, SC51089. J Neuro-Oncol. 2004; 66: 285-292.